ITC Rules in Favor of ZMC in Coq10 Litigation
The U.S. International Trade Commission (“ITC”) issued a notice terminating the patent infringement investigation brought by Kaneka Corporation with a finding of no violation by Zhejiang Medicine Co., Ltd. (“ZMC”).
05 Dec 2012 --- The U.S. International Trade Commission (“ITC”) has issued a notice terminating the patent infringement investigation brought by Kaneka Corporation with a finding of no violation by Zhejiang Medicine Co., Ltd. (“ZMC”).
The ITC instituted an investigation on July 19, 2011, based on a complaint filed by Kaneka on June 17, 2011 under Section 337 of the Tariff Act of 1930. Kaneka’s complaint alleged that ZMC’s process for making coenzyme Q10 infringes Kaneka’s patent, U.S. Patent No. 7,910,340 (“the ‘340 patent”).
To contact our editorial team please email us at editorial@cnsmedia.com
Subscribe now to receive the latest news directly into your inbox.
